New DNA test could speed up fungal infection diagnosis in cancer patients

NCT ID NCT03349931

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated Apr 30, 2026 · Updated 17 times

Summary

This study tested a new DNA test (MycoGenie kit) to see how well it can detect a serious fungal infection called invasive aspergillosis in blood cancer patients. The test looks for the fungus's DNA in blood samples and can also check if the fungus is resistant to common medicines. The study involved 350 adults with blood cancers or those who had a stem cell transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHRU de Lille, Hôpital Claude Huriez

Lille, 59000, France
CHU Bordeaux, Groupe hospitalier

Bordeaux, 33000, France
CHU de DIJON, Hôpital du bocage

Dijon, 21000, France
CHU de Nantes, Hôpital de Moncousu

Nantes, 44000, France
CHU de RENNES, hôpital de Pontchaillou

Rennes, 35000, France
Hôpital Necker - Enfants maladies (AP-HP)

Paris, Paris, 75015, France

Conditions

Explore the condition pages connected to this study.

INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES